Jonathan Fox
Präsident bei EIDOS THERAPEUTICS, INC.
Vermögen: 185 980 $ am 31.05.2024
Aktive Positionen von Jonathan Fox
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EIDOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 | - |
Präsident | 01.10.2016 | - | |
Direktor/Vorstandsmitglied | 01.10.2016 | - | |
Corporate Officer/Principal | 01.10.2016 | - | |
EDGEWISE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 02.03.2023 | - |
Independent Dir/Board Member | 02.03.2023 | - | |
BRIDGEBIO PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Präsident | - | - | |
ML Bio Solutions, Inc. | Direktor/Vorstandsmitglied | - | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jonathan Fox
Ehemalige bekannte Positionen von Jonathan Fox
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MYOKARDIA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2013 | 30.09.2016 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2012 |
Stanford University | Corporate Officer/Principal | - | - |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Jonathan Fox
The University of Chicago | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 4 |
Sektoral
Health Technology | 9 |
Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
ML Bio Solutions, Inc. | |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
- Börse
- Insiders
- Jonathan Fox
- Erfahrung